Start a new application to McKinsey, retrieve your draft application(s) or access
or update your online account.
To ensure the security of your profile information, please re-enter your password.
Don’t have an account? Register here.
Register to get full access to our articles and reports, including those by McKinsey
Quarterly and the McKinsey Global Institute, and to subscribe to our newsletters
and e-mail alerts.
Gain full access to articles and reports, including those by McKinsey Quarterly
and the McKinsey Global Institute, and subscribe to our newsletters and e-mail alerts.
Sorry, something went wrong and we cannot reset your password right now. Please
try again later.
Please enter the e-mail address you use to sign into your account.
If your e-mail address is associated with an account in our system, we have sent
you instructions on how to reset your password.
July 2015—Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales focus to an access-driven commercial model must occur.more
June 2015—CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.more
June 2015—Africa may be the only pharmaceutical market where genuinely high growth is still achievable. Here’s what’s driving that strength and how companies should react.more
April 2015—Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit growth is possible, but will require a granular approach.more
March 2015—The country’s population, already the world’s oldest, is aging quickly. Companies in Europe, North America, and Asia can learn from its experience.more
January 2015—The growing demand for products that are “good enough” and competitively priced has pushed medical-product manufacturers to develop strategies to attract and retain this new segment of customers.more
January 2015—Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.more
December 2014—Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations.more
November 2014—Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving.
September 2014—Successful large, transformative deals are rare in medical devices. With further consolidation ahead, future acquirers need to reconsider their approach in the context of a programmatic M&A strategy.more
September 2014—A decade of restructuring and transformation efforts has taken a toll on organizational health.more
October 2014—How does a global company take advantage of digital technology? Johnson & Johnson’s vice president of digital strategy, Gail Horwood, explains.more
September 2014—What’s the value of bringing a drug to market first? In some cases, it may be less than you think.more
The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.
The creation of knowledge supports McKinsey’s core mission: helping our clients achieve distinctive, lasting, and substantial performance improvements. We publish our insights and those of external experts to help advance the practice of management and provide leaders with facts on which to base business and policy decisions. Views expressed by third-party authors are theirs alone.